Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Preferred Shares Issued (2020)

Historic Preferred Shares Issued for Viridian Therapeutics, Inc.\DE (VRDN) over the last 1 years, with Q4 2020 value amounting to $91.0 million.

  • Viridian Therapeutics, Inc.\DE's Preferred Shares Issued changed N/A to $91.0 million in Q4 2020 from the same period last year, while for Dec 2023 it was $91.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $25.0 million for FY2024, which is N/A changed from last year.
  • As of Q4 2020, Viridian Therapeutics, Inc.\DE's Preferred Shares Issued stood at $91.0 million.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Preferred Shares Issued ranged from a high of $91.0 million in Q4 2020 and a low of $91.0 million during Q4 2020